{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:27:15Z","timestamp":1781069235288,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jpba.2024.116330","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T07:13:54Z","timestamp":1719558834000},"page":"116330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Highly sensitive two-dimensional ion chromatography mass spectrometry method for nitrite determination in hydroxypropyl methylcellulose"],"prefix":"10.1016","volume":"248","author":[{"given":"Koudi","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kerry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Serr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Mintert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Pursch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan","family":"Eeltink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Desmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116330_bib1","first-page":"521","article-title":"The effects of nitrate, nitrite and N-nitroso compounds on human health: a review","volume":"35","author":"Bruning-Fann","year":"1993","journal-title":"Vet. Hum. Toxicol."},{"key":"10.1016\/j.jpba.2024.116330_bib2","unstructured":"Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, IARC, v 89, 2007. \u3008https:\/\/publications.iarc.fr\/107\u3009."},{"key":"10.1016\/j.jpba.2024.116330_bib3","unstructured":"EMA, Questions and answers for marketing authorisation holders\/applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726\/2004 referral on nitrosamine impurities in human medicinal products. EMA\/409815\/2020 Rev. 20. \u3008https:\/\/www.ema.europa.eu\/en\/documents\/referral\/nitrosamines-emea-h-a53-1490-questions-answers-marketing-authorisation-holders-applicants-chmp-opinion-article-53-regulation-ec-no-726-2004-referral-nitrosamine-impurities-human-medicinal-products_en.pdf\/\u3009, 2024 (Accessed 18 June 2024)."},{"key":"10.1016\/j.jpba.2024.116330_bib4","unstructured":"FDA, Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities, Guidance for Industry. FDA-2020-D-1530. \u3008https:\/\/www.regulations.gov\/document\/FDA-2020-D-1530-0032\/\u3009, 2024 (Accessed 18 June 2024)."},{"key":"10.1016\/j.jpba.2024.116330_bib5","unstructured":"ECA academy, Valsartan: what caused the contamination? Available at: \u3008https:\/\/www.gmp-compliance.org\/gmp-news\/valsartan-what-caused-the-contamination\/\u3009, 2024 (Accessed 18 June 2024)."},{"key":"10.1016\/j.jpba.2024.116330_bib6","unstructured":"FDA news release, FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications December 11, 2018. Available at: \u3008https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm628189.htm\/\u3009, 2024 (accessed 18 June 2024)."},{"key":"10.1016\/j.jpba.2024.116330_bib7","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1021\/acs.jmedchem.0c02120","article-title":"Critical analysis of drug product recalls due to nitrosamine impurities","volume":"64","author":"Bharate","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2024.116330_bib8","unstructured":"Recalls, Market Withdrawals, & Safety Alerts. \u3008https:\/\/www.fda.gov\/safety\/recalls-market-withdrawals-safety-alerts\/\u3009, 2024 (Accessed 18 June 2024)."},{"key":"10.1016\/j.jpba.2024.116330_bib9","unstructured":"Health Canada. Guidance on nitrosamine impurities in medications. Available at: \u3008https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/compliance-enforcement\/information-health-product\/drugs\/nitrosamine-impurities\/medications-guidance.html\/\u3009, 2024 (Accessed 18 June 2024)."},{"key":"10.1016\/j.jpba.2024.116330_bib10","unstructured":"FDA. Control of nitrosamine impurities in human drugs. Available at: \u3008https:\/\/www.fda.gov\/media\/141720\/download\/\u3009, 2024 (accessed 18 June 2024)."},{"key":"10.1016\/j.jpba.2024.116330_bib11","unstructured":"EMA. Nitrosamine impurities in human medicinal products. 2020. Available at: \u3008https:\/\/www.ema.europa.eu\/en\/documents\/referral\/nitrosamines-emea-h-a53-1490-assessment-report_en.pdf\/\u3009, 2024 (Accessed 18 June 2024)."},{"key":"10.1016\/j.jpba.2024.116330_bib12","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1021\/acs.oprd.0c00224","article-title":"Potential for the formation of N-nitrosamines during the manufacture of active pharmaceutical ingredients: an assessment of the risk posed by trace nitrite in water","volume":"24","author":"Ashworth","year":"2020","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.jpba.2024.116330_bib13","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1021\/acs.oprd.0c00323","article-title":"Pathways for N-nitroso compound formation: secondary amines and beyond","volume":"24","author":"Lopez-Rodriguez","year":"2020","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.jpba.2024.116330_bib14","unstructured":"A. Berardi, P.H.M. Janssen, B.H.J. Dickhoff, S. Van Gessel, Nitrosamine risk mitigation: the critical role of excipients and supplier qualification, DFE pharma, Goch, Germany. Available at: \u3008https:\/\/dfepharma.com\/media\/44hnkq2p\/nitrosamineswhite-paper.pdf\/\u3009, 2024 (accessed 18 June 2024)."},{"key":"10.1016\/j.jpba.2024.116330_bib15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0378-4347(00)00264-4","article-title":"Ion chromatographic method for simultaneous determination of nitrate and nitrite in human saliva","volume":"744","author":"Helaleh","year":"2000","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2024.116330_bib16","unstructured":"F. Pang, T. Christion, Determination of nitrite and nitrate in wastewater using capillary IC with UV detection. \u3008https:\/\/tools.thermofisher.com\/content\/sfs\/brochures\/113697-AU185-IC-Nitrate-Nitrite-Wastewater-06Aug2012-AU70208_E.pdf\/\u3009, 2024 (Accessed 18 June 2024)."},{"key":"10.1016\/j.jpba.2024.116330_bib17","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/jaoac\/89.3.712","article-title":"Determination of nitrite, nitrate, and glucose-6-phosphate in muscle tissues and cured meat by IC\/MS","volume":"89","author":"Saccani","year":"2006","journal-title":"J. Aoac. Int."},{"key":"10.1016\/j.jpba.2024.116330_bib18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.exer.2012.01.014","article-title":"Using the Griess colorimetric nitrite assay for measuring aliphatic \u03b2-nitroalcohols","volume":"98","author":"Wen","year":"2012","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jpba.2024.116330_bib19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jpba.2011.08.017","article-title":"Evaluation of an LC-MS\/MS assay for 15N-nitrite for cellular studies of L-arginine action","volume":"56","author":"Shin","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116330_bib20","article-title":"Nitrites as precursors of N-nitrosation in pharmaceutical samples \u2013 a trace level analysis","volume":"213","author":"Jire\u02c7s","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116330_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0378-4347(94)00374-2","article-title":"Quantification of nitrite and nitrate in human urine and plasma as pentafluorobenzyl derivatives by gas chromatography-mass spectrometry using their N-labeled analogs","volume":"661","author":"Tsikas","year":"1994","journal-title":"J. Chromatogr. B. Biomed. Appl."},{"key":"10.1016\/j.jpba.2024.116330_bib22","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.xphs.2022.04.016","article-title":"A nitrite excipient database: a useful tool to support N-Nitrosamine risk assessment for drug products","volume":"112","author":"Boetzel","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2024.116330_bib23","unstructured":"S. Hickert, U. Reichert, J. Schlingemann, Managing nitrite impurities: A combined supplier-manufacturer view to nitrosamine risks. Webinar by sigma Aldrich, Darmstadt, Germany, 28-Sep-2023."},{"key":"10.1016\/j.jpba.2024.116330_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115648","article-title":"Parts per billion of nitrite in microcrystalline cellulose by ion chromatography mass spectrometry with isotope labeled internal standard","volume":"235","author":"Zhu","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116330_bib25","series-title":"Handbook of Pharmaceutical Wet Granulation: Theory and Practice in a Quality by Design Paradigm","first-page":"317","article-title":"Binders in wet granulation","author":"D\u00fcrig","year":"2019"},{"key":"10.1016\/j.jpba.2024.116330_bib26","first-page":"972A","article-title":"From ions in solution to ions in the gas phase - the mechanism of electrospray mass spectrometry","volume":"65","author":"Kebarle","year":"1993","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116330_bib27","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1044-0305(03)00574-9","article-title":"Matrix effect in bio-analysis of illicit drugs with LC-MS\/MS: influence of ionization type, sample preparation, and biofluid","volume":"14","author":"Buhrman","year":"2003","journal-title":"J. Am. Soc. Mass. Spectrom."},{"key":"10.1016\/j.jpba.2024.116330_bib28","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1021\/ac00208a012","article-title":"Investigations of the electrospray interface for liquid chromatography\/mass spectrometry","volume":"62","author":"Ikonomou","year":"1990","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116330_bib29","first-page":"498","article-title":"Ion suppression: a major concern in mass spectrometry","volume":"24","author":"Volmer","year":"2006","journal-title":"LC Gc N. Am."},{"key":"10.1016\/j.jpba.2024.116330_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.chroma.2018.04.017","article-title":"detection of anions and cations in mineral water by two dimensional ion chromatography","volume":"1554","author":"Fa","year":"2018","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116330_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.463908","article-title":"Applications of two-dimensional ion chromatography for analytes determination in environmental matrix: a review","volume":"1694","author":"Yang","year":"2023","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116330_bib32","unstructured":"How to dissolve HPMC(Hydroxypropyl Methyl Cellulose) correctly? What is the specific methods? Available at: \u3008https:\/\/www.celotech.com\/technology\/how-to-dissolve-hpmchydroxypropyl-methyl-cellulose-correctly-what-is-the-specific-methods\/\u3009, 2024 (accessed 18 June 2024)."},{"key":"10.1016\/j.jpba.2024.116330_bib33","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1021\/ic202081z","article-title":"Accurate rate constants for decomposition of aqueous nitrous acid","volume":"51","author":"Rayson","year":"2012","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jpba.2024.116330_bib34","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/01496395.2019.1577263","article-title":"Reduction of nitrate to nitrite in water by acid-washed zero-valent zinc","volume":"55","author":"Chiu","year":"2019","journal-title":"Sep. Sci. Technol."},{"key":"10.1016\/j.jpba.2024.116330_bib35","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1021\/ac020280w","article-title":"Simulation and optimization of retention in ion chromatography using virtual column 2 software","volume":"74","author":"Madden","year":"2003","journal-title":"Ana. Chem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524003704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524003704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T03:45:56Z","timestamp":1726890356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524003704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":35,"alternative-id":["S0731708524003704"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116330","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly sensitive two-dimensional ion chromatography mass spectrometry method for nitrite determination in hydroxypropyl methylcellulose","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116330"}}